PsyBio Therapeutics Corp

PINK:PSYBF USA Biotechnology

Market Cap

$8.09K

Market Cap Rank

#47870 Global

#14750 in USA

Share Price

$0.00

Change (1 day)

+0.00%

52-Week Range

$0.00 - $0.00

All Time High

$0.51

PsyBio Therapeutics Corp - Asset Resilience Ratio

Latest as of June 2022: 65.96%

PsyBio Therapeutics Corp (PSYBF) has an Asset Resilience Ratio of 65.96% as of June 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$853.14K

Cash + Short-term Investments

Total Assets

$1.29 Million

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2021)

This chart shows how PsyBio Therapeutics Corp's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down PsyBio Therapeutics Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$853.14K	65.96%
Total Liquid Assets	$853.14K	65.96%

Asset Resilience Insights

Very High Liquidity: PsyBio Therapeutics Corp maintains exceptional liquid asset reserves at 65.96% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.